Precision Neuroscience Stock
| Valuation | $542.69M1, 2 |
| Valuation Date | Dec 16, 2024 |
| Implied Valuation | $1.49B |
| Last Price | $8.14 |
| 52-Week High | $8.61 |
| 52-Week Low | $5.66 |
| YTD Return | +34.99% |
| 1-Year Return | +43.06% |
| 3-Year Return | n/a |
| Total Funding | $182.65M1 |
| Latest Round Amount | $102M3 |
| Latest Round | Series C |
| Funding Rounds | 4 |
| IPO Status | Unknown |
| Expected IPO Date | n/a |
| Revenue | n/a |
| Revenue Type | n/a |
| P/S Ratio | n/a |
About Precision Neuroscience
Precision Neuroscience is a brain-computer interface company that develops a minimally invasive brain implant for people with severe paralysis. Its Layer 7 Cortical Interface is a thin film with 1,024 electrodes that conforms to the surface of the brain without penetrating tissue. It is inserted through a slit less than a millimeter wide and can be safely removed. The implant records neural signals that let users operate computers and smartphones with their thoughts. The company plans to make money by commercializing its implant system for clinical uses such as intraoperative brain mapping, and the Layer 7 array received FDA clearance in 2025 for implantations of up to 30 days. Precision was co-founded by Benjamin Rapoport, a neurosurgeon who was part of the founding team of Neuralink.
Invest in Precision Neuroscience
Precision Neuroscience is a private company, so you can't purchase it with a regular brokerage account. However, its shares are available on Hiive.
Hiive is a secondary marketplace where accredited investors can buy and sell shares of private, pre-IPO companies. Invest in the world's most exciting startups before they go public.
Invest on HiiveStock Analysis may be compensated for user sign-ups through Hiive links. Hiive is not affiliated with Stock Analysis. Securities offered by Hiive Markets Limited, member of FINRA/SIPC.
Related Companies
News
Precision Neuroscience appoints BCI pioneer John Donoghue as scientific advisor
The company named Brown University professor John Donoghue, a pioneer of brain-computer interfaces, as scientific advisor to guide device design, signal decoding, and clinical strategy.
Precision Neuroscience demonstrates thought-based gaming in non-paralysed volunteers
Precision Neuroscience said non-paralyzed study participants used its Layer 7 cortical array to control games and apps—including Pong, Mario Kart, and FaceTime—with thought alone during short hospital...
Precision Neuroscience and Medtronic Partner on Layer 7 BCI Integration
Precision Neuroscience announced a strategic partnership with Medtronic to integrate its Layer 7 cortical brain-computer interface with Medtronic's StealthStation surgical navigation system for neuros...
Medtronic inks deal to build brain computer interface into surgical system
Medtronic and Precision Neuroscience will co-develop an integrated system pairing Precision's Layer 7 cortical interface with Medtronic's StealthStation surgical navigation platform.
Precision Neuroscience and Medtronic Partner to Integrate Layer 7 Brain-Computer Interface with Medtronic Neurosurgical Platform
Precision Neuroscience announced a strategic partnership with Medtronic to co-develop a system that combines its Layer 7 cortical interface with Medtronic's StealthStation surgical navigation platform...
Precision Neuroscience receives investment from SCI Ventures
Precision Neuroscience announced in November 2025 an investment from SCI Ventures, a paralysis-focused venture fund backed by the Christopher & Dana Reeve Foundation and other spinal cord injury organ...
Precision Neuroscience inks partnership with venture fund backed by spinal cord injury advocates
SCI Ventures, a paralysis-focused venture fund backed by the Christopher & Dana Reeve Foundation, Wings for Life and other spinal cord injury organizations, made a seven-figure investment in Precision...
Neuralink rival Precision Neuroscience gets FDA clearance for key part of its brain implant
The FDA granted 510(k) clearance to Precision Neuroscience's Layer 7 Cortical Interface, a 1,024-electrode array that can be implanted for up to 30 days. The company says it is the first full regulato...
FDA clears Precision Neuroscience Layer 7 cortical interface
Precision Neuroscience received FDA 510(k) clearance in March 2025 for its Layer 7 Cortical Interface, authorizing temporary brain-surface recording and stimulation for up to 30 days.
Precision Neuroscience Raises $102 Million to Advance AI-Powered Brain Implant
Precision Neuroscience closed a $102 million Series C round led by General Equity Holdings, with participation from B Capital, Stanley Druckenmiller's Duquesne Family Office and Steadview Capital, bri...
Neuralink competitor Precision Neuroscience is testing its brain implant in humans
CNBC observed Precision Neuroscience testing its brain-computer interface in patients at Mount Sinai Health System, where the company set an industry record by using four of its electrode arrays at on...